click below
click below
Normal Size Small Size show me how
BMC - PHARMACOLOGY
QUIZES
| Question | Answer |
|---|---|
| DRUGS THAT CAN BE OBTAINED ONLY THROUGH A VETERINARIAN OR VIA A PRESCRIPTION | PRESCRIPTION DRUGS |
| DRUGS THTA CAN BE PURCHASED WITHOUT A PRESCRIPTION | OVER-THE-COUNTER DRUGS |
| STUDY OF DRUG'S MECHANISM OF ACTION AND ITS BIOLOGICAL AND PHYSIOLOGICAL EFFECTS | PHARMACODYNAMICS |
| DRUGS USED IN A MANNER NOT SPECIFICALLY DESCRIBED ON FDA-APPROVED LABEL | EXTRA-LABEL DRUGS |
| THE TREATMENT OF DISEASE WITH DRUGS | PHARMACOTHERAPY |
| THE STUDY AND USE OF DRUGS IN ANIMAL HEALTHCARE | VETERINARY PHARMACOLOGY |
| STUDY OF ABSORPTION, BLOOD LEVELS, DISTRIBUTION, METABOLISM AND EXCRETION OF DRUGS | PHARMACOKINETICS |
| PERCENT OF DRUG ADMINISTERED THAT ENTERS THE SYSTEMIC CIRCULATION | BIOAVAILABILITY |
| MOVEMENT OF DRUGS FROM THE SYSTEMIC CIRCULATION TO THE TISSUES | DRUG DISTRIBUTION |
| THE AGENCY THAT OVERSEES THE DEVELOPMENT AND SALE OF PRESCRIPTION DRUGS IS THE ______________ | FDA |
| ___________ARE DRUGS THAT CAUSE AN ACTION AFTER BINDING TO A RECEPTOR, AND ___________ARE DRUGS THAT BLOCK AN ACTION AFTER BINDING TO A RECEPTOR | AGONISTS, ANTAGONISTS |
| __________IS THE STRENGTH OF BINDING BETWEEN A DRUG AND ITS RECEPTOR | AFFINITY |
| LIST THE FOUR STEPS OF PHARMACOKINETICS | ABSORPTION, DISTRIBUTION, METABOLISM, EXCRETION |
| WHICH OF THE FOLLOWING IS USED TO TREAT BLEEDING DISORDERS A. HEPARIN B. VITAMIN K C. EDTA D. SILVER NITRATE STICKS | B. VITAMIN K |
| ERYTHROPOIETIN IS USED TO | INCREASE RBC PRODUCTION |
| HEPARIN IS USED IN THE TREATMENT OF | BLOOD CLOTS |
| WHICH CARDIOVASCULAR DRUG SHOULD BE MONITORED FOR TOXICITY LEVELS THROUGH BLOOD TESTING | DIGOXIN |
| DIURETICS ARE USED IN THE TREATMENT OF | HEART DISEASE |
| DILTIAZEM IS USED IN THE TREATMENT OF | ARRYTHMIAS |
| WHAT HEART VALVE SEPERATES THE LEFT ATRIUM FROM THE LEFT VENTRICLE | MITRAL |
| WHERE DO THE ELECTRICAL IMPULSES THAT STIMULATE NORMAL CONTRACTION OF THE HEART ORIGINATE | THE SA NODE |
| WHAT ARE THE SAMLL VESSELS CALLED THAT ALLOW DIFFUSION OF OXYGEN AND NUTRIENTS INTO TISSUE | CAPILLARIES |
| LIDOCANE CAN BE USED IN THE TREATMENT OF | ARRYTHMIAS |
| ACE INHIBITOR | ENALAPRIL |
| BETA ADRENERGIC BLOCKER | PROPANOLOL |
| LOOP DIURETIC | FUROSEMIDE |
| CALCIUM CHANNEL BLOCKER | AMLODIPINE |
| ANTICOAGULANT | HEPARIN |
| BLOOD FLOW THROUGHT THE HEART | VENA CAVA; RIGHT ATRIUM; RIGHT VENTRICLE; LUNGS; LEFT ATRIUM; LEFT VENTRICLE; AORTA |
| DRUGS CONSIDERED DANGEROUS BECAUSE OF THEIR POTENTIAL FOR HUMSN ABUSE OR MISUSE | CONTROLLED SUBSTANCE |
| DRUG DOSAGE OR DOSE THAT PRODUCES THE DESIRED EFFECT WITH MINIMAL OR NO SIGNS OF TOXICITY | THERAEUTIC INDEX |
| BRAND NAME GIVEN TO A DRUG BY A SPECIFIC MANUFACTURER | TRADE NAME |
| THE DATE BEFORE WHICH A DRUG MEETS ALL SPECIFICATIONS AND AFTER WHICH THE DRUG SHOULD NO LONGER BE USED | EXPIRATION DATE |
| DESCRIBES THE SITUATINS IN WHICH A DRUG SHOULD NOT BE USED | CONTRAINDICATIONS |
| AGENCY THAT OVERSEES AND ENFORCES REGULATIONS OF CONTROLLED SUBSTANCES | DRUG ENFORCEMENT AGENCY |
| THE HIGHER THE SCHEDULE NUMBER (FOREXAMPLE, V VERSUS I) OF A CONTROLLED-SUBSTANCES DRUG | THE LOWER THE RISK FOR HUMAN ABUSE POTENTIAL |
| WHICH THERAPEUTIC INDEX IS THE SAFEST OF THOSE LISTED BELOW | 30 |
| THE MARGIN OF SAFETY IS OFTEN REFERRED TO AS | THE SAFTEY PARAMETER |
| A DRUG THAT HAS A MARGIN OF SAFTEY OF 75 IS | SAFER THAN A DRUG WHOSE MARGIN OF SAFETY IS 5 |
| WHAT IS THE DIFFERENCE BETWEEN THE GENERIC NAME AND THE TRADE NAME OF A DRUG | THE GENERIC NAME IS USUALLY A CHEMICAL NAME OR SHORT-HAND CHEMICAL NAME. THE TRADE NAME IS THE NAME GIVEN TO THE DRUG PRODUCT IN EACH SPECIFIC FORM BY THE PHARMACEUTICAL MANUFACTURER |
| POLYURIA | URINATING MORE THAN NORMAL |
| DYSURIA | HAVING DIFFICULTY URINATING (PAINFUL) |
| POLLAKIURIA | FREQUENT URINATION |
| STRANGURIA | STRAINING TO URINATE |
| HEMATURIA | BLOODY URINE |
| NAME TWO THINGS THAT AFFECT GLOMERULAR FILTRATION RATE | BLOOD VOLUME, BLOOD PRESSURE |
| DIURETICS INCREASE OR DECREASE THE VOLUME OF URINE EXCRETED BY THE KIDNEYS | INCREASE |
| WATER FOLLOWS ________ | SODIUM |
| WHICH ELECTROLYTE DO WE WORRY ABOUT LOSING TOO MUCH OF WHEN USING DIURETICS | POTASSIUM |
| IDENTIFY WHETHER THE FOLLOWING FACTORS INCREASE OR DECREASE BLOOD PRESSURE 1. INCREASED BLOOD VOLUME 2. VASODILATION 3. INCREASED PERIPHERAL RESISTANCE | 1. INCREASE 2. DECREASE 3. INCREASE |
| WHICH TWO TYPES OF COMMON UROLITHS CANNOT BE SEEN ON RADIOGRAPHS | CYSTINE AND URATE |
| THE INTERNAL SPHINCTER OF THE BLADDER IS COMPOSED OF SKELETAL OR SMOOTH MUSCLE | SMOOTH |
| WHICH NEUROTRANSMITTER IS USED TO MAKE MUSCLES CONTRACT | ACETYLCHOLINE |
| NAME A REASON THAT NEUROMUSCULAR BLOCKERS ARE USED | PARALYSIS |
| INFLAMMATION = REDNESS + PAIN + HEAT + _____________ | SWELLING |
| ATIPAMEZOLE | ALPHA-2 ANTAGONIST; ANTISEDAN; REVERSAL AGENT FOR ALPHA-2 AGONISTS |
| ATROPINE | ANTICHOLINERGIC; PREANESTHETIC TO PREVENT BRADYCARDIA AND DECREASE SALIVATION, DILATE PUPILS AND CONTROL CILIARY SPASM |
| APOMORPHINE | OPIOID; USED TO INDUCE EMESIS |
| BUPRENORPHINE | OPIOID; BUPRENEX; SUBUTEX; ANALGESIA |
| BUTORPHANOL | OPIOID; TORBUGESIC, TORBUTROL; |
| DEXMEDETOMIDINE | ALPHA-2 AGONIST DEXDOMITOR, DOMITOR, SEDATION, ANAGESIA |
| DIAZEPAM | BENZODIAZEPINE; VALIUM; ANTICONVULSANT, MUSCLE RELAXATION, ANTIANXIETY |
| DOXAPRAM | RESPIRATORY STIMULANT; DOPRAM-V, RESPIRAM; INCREASED RESPIRATIONS AND CNS STIMULATION |
| EPINEPHRINE | ADRENERGIC; ADENALIN; EMERGENCY CPR; ANAPHYLAXIS TREATMENT |
| FENTANYL | OPIOID; DURAGESIC; ANALGESIA |
| GABAPENTIN | GABA RECEPTO AGONIST; NEURONTIN; ANTICONVULSANT ADD-ON. CHRONIC PAIN ADD-ON |
| GLYCOPYRROLATE | ANTICHOLINERGIC; ROBINUL-V; PREANESTHETIC TO PREVENT BRADYCARDIA |
| HYDROCODONE | OPIOID; HYCODAN, TUSSIGON, ANTITUSSIVE |
| HYDROMORPHONE | OPIOID; DILAUDID; ANALGESIA, PREANESTHETIC |
| ISOFLURANE | HALOGENATED ETHER; ISOFLO, ISOSOL, FORANE; INHALANT ANESTHETIC |
| KETAMINE | DISSOCIATIVE; KETASET; KETALAR; VETALAR; INJECTABLE ANESTHETIC |